The 62nd Annual Meeting of the Scientific and Standardization Committee (SSC) of the International Society on Thrombosis and Haemostasis (ISTH) will be held May 25-28, 2016, in Montpellier, France. Learn more about SSC 2016 from Meeting President Jean-François Schved below:

ISTH: What will be the focus of the 2016 SSC Meeting, and what highlights can participants expect?

schved_2

Jean-François Schved

JFS: Besides subcommittee sessions, the 2016 SSC meeting program will include four educational sessions, one plenary session and two trainee sessions covering a large spectrum of topics in the field of thrombosis and hemorrhagic diseases. Therapeutic approaches are evolving very quickly, and new treatments will be available in 2016. Thus, a special focus will concern treatments: new treatments targeting platelets, coagulation or thrombolysis and new approaches in therapy: cell-based therapy, gene therapy. Another important part of the educational session will concern vascular medicine and biology. More and more, labs in various countries are acquiring techniques for diagnosis or therapeutic follow-up. Thus, standardization remains a critical point in various fields.

 

ISTH: How will this SSC Meeting differ from those in the past?

JFS: The Scientific Committee tried to build a program that may be interesting for clinicians, biologists or researchers coming from different specialties, but also from different parts of the world, including emerging countries. So different aspects of research or modern approaches in hemostasis and thrombosis will be considered, and an important part of the program will focus on the possibilities for physicians or biologists of emerging countries to develop methods of care, exploration or research in hemostasis and thrombosis.

 

ISTH: Why should someone consider attending SSC 2016?

JFS: Between Toronto 2015 and Berlin 2017 ISTH Congresses, the SSC 2016 meeting in Montpellier will be the largest international meeting on thrombosis and hemostasis. Participants will have the opportunity to meet colleagues from all parts of the world, and they will have access to the newest information in this field.  Also, France is an easy destination to visit, and Montpellier can be reached quickly by direct flights, trains and frequent connecting flights from Paris. While many topics will be developed, the low registration fees and the size of the meeting will allow colleagues who have difficulties attending a large international congress to participate in this event.

 

ISTH: Tell us a little bit about Montpellier and what participants can look forward to when planning their trip.

JFS: Founded in 985 on the Mediterranean shore between Italy and Spain, Montpellier has always been a multi-cultural crossroads in trade and science. This former medieval city where Rabelais and Nostradamus studied is now an international center in medicine and science with world-class venues for international events. In March 2010, France elected Montpellier as their favorite place to live. The study was based on multiple factors including: the quality of its environment and the lack of pollution; sunny weather (300 days of sun per year); and its friendly atmosphere. And with its monuments, architecture and famous museums (Musee Fabre, Musee d’anatomie), Montpellier was the only French city listed as one of “The 45 places to go in 2012,” according to the New York Times.

Learn more at SSC2016.org.

By |June 9, 2015